Jilin Province Huinan Changlong Bio-pharmacy Company Limited (8049.HK)

HKD 1.39

(-0.71%)

Annual Income Statements

(In CNY)
Breakdown 2023 2022 2021 2020 2019 2018
Revenue 841.54 Million 841.58 Million 705.45 Million 622.25 Million 645.88 Million 647.67 Million
Cost of Revenue 257.49 Million 193.55 Million 125.45 Million 91.51 Million 107.53 Million 115.55 Million
Gross Profit 584.04 Million 648.03 Million 580 Million 530.73 Million 538.35 Million 532.11 Million
Operating Expenses 385.21 Million 494.15 Million 444.09 Million 417.18 Million 389.37 Million 387.59 Million
Selling, General and Administrative Expenses 449.3 Million 509.94 Million 454 Million 428.35 Million 400.9 Million 403.93 Million
Research and Development Expenses 13.1 Million 19.06 Million 20.57 Million 33.19 Million 11.63 Million 334 Thousand
Other Expenses -77.19 Million -15.79 Million -9.91 Million -11.16 Million -11.53 Million -16.34 Million
Cost and Expenses 642.71 Million 687.7 Million 569.54 Million 508.7 Million 496.9 Million 503.14 Million
Operating Income 198.82 Million 197.82 Million 177.61 Million 150.75 Million 175.41 Million 186.37 Million
Interest Expense 515 Thousand 477 Thousand 344 Thousand 713 Thousand 120 Thousand 53 Thousand
Income Tax Expense 50.1 Million 3.78 Million 33.99 Million 23.48 Million 30.56 Million 25.1 Million
Earnings before Tax 198.31 Million 197.34 Million 177.27 Million 150.04 Million 175.29 Million 186.32 Million
Net Income 148.2 Million 193.56 Million 143.28 Million 126.55 Million 144.72 Million 161.21 Million
Earnings Per Share Basic 0.26 0.35 0.26 0.23 0.26 0.29
Earnings Per Share Diluted 0.26 0.35 0.26 0.23 0.26 0.29
Weighted Average Shares Outstanding 560.25 Million 560.25 Million 560.25 Million 560.25 Million 560.25 Million 560.25 Million
Weighted Average Shares Outstanding (Diluted) 560.25 Million 560.25 Million 560.25 Million 560.25 Million 560.25 Million 560.25 Million
Gross Margin 0.69 0.77 0.82 0.85 0.83 0.82
EBIT Margin 0.27 0.26 0.28 0.26 0.27 0.27
Profit Margin 0.18 0.23 0.20 0.20 0.22 0.25
EBITDA 226.38 Million 231.42 Million 206.49 Million 172.91 Million 196.73 Million 206.16 Million
Earnings Before Tax Margin 0.24 0.24 0.25 0.24 0.27 0.29

Income Statement Charts